European Journal of Pediatrics

, Volume 152, Issue 4, pp 348–349 | Cite as

Non-specific elevation of immunoreactive trypsinogen in sick infants

  • D. Ravine
  • R. I. Francis
  • D. M. Danks


To determine the effect of neonatal illness on immunoreactive trypsinogen (IRT) levels, the IRT values obtained in sick infants transferred to a neonatal intensive care ward were compared with those found in matched controls. IRT levels from dried blood spots collected on day 4–5 of life from 372 sick infants had a mean value of 0.095 log transformed multiples of the median, whilst controls had a mean of −0.013: a highly significant difference. Classification of the sick infants into principal diagnostic categories failed to show any group contributing disproportionately to the observation. In particular, the level of elevation observed in 33 infants with gut abnormalities such as bowel obstruction, duodenal atresia, exomphalos and gastroschisis, in which some degree of pancreatic obstruction might be expected, was not greater than in other hospitalised infants. These data show that sick infants are at increased risk of being identified by an IRT screening programme aimed at detecting infants with cystic fibrosis.

Key words

Trypsinogen Neonatal Screening Cystic fibrosis 



cystic fibrosis


immunoreactive trypsinogen


  1. 1.
    Bowling FG, Brown ARD (1988) Newborn screening for cystic fibrosis using an enzyme-linked immunosorbent assay (ELISA) technique. Clin Chim Acta 171:157–262Google Scholar
  2. 2.
    Bowling FG, McGill JJ, Danks DM (1990) Newborn screening for cystic fibrosis: use of F508 mutation. Lancet I:925–926Google Scholar
  3. 3.
    Crossley JR, Elliott RB, Smith PA (1979) Dried-blood spot screening for cystic fibrosis in the newborn. Lancet I:472–474Google Scholar
  4. 4.
    King A, Mueller RF, Heeley AF, Roberton NRC (1986) Diagnosis of cystic fibrosis in premature infants. Pediatr Res 20: 536–541Google Scholar
  5. 5.
    Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Leassig RH (1989) Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test. Pediatr Pulmonol 6:42–48Google Scholar
  6. 6.
    Ryley HC, Deam SM, Williams J, Alfaham M, Weller PH, Goodchild MC, Darter RA, Bradley D, Doge JA (1988) Neonatal screening for cystic fibrosis in Wales and the West Midlands. 1. Evaluation of immunoreactive trypsin test. J Clin Pathol 41:726–729Google Scholar
  7. 7.
    Wilcken B (1987) An evaluation of screening for cystic fibrosis. Genetics and epithelial cell dysfunction in cystic fibrosis. Liss, New York, pp 201–215Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • D. Ravine
    • 1
  • R. I. Francis
    • 1
  • D. M. Danks
    • 1
  1. 1.Murdoch InstituteRoyal Children's HospitalParkvilleAustralia

Personalised recommendations